Skip to main navigation
Skip to search
Skip to main content
University of Copenhagen Research Portal Home
Help & FAQ
Dansk
English
Home
Profiles
Research output
Research units
Press/Media
Activities
Prizes
???studenttheses???
Datasets
Search by expertise, name or affiliation
Escitalopram in the treatment of social anxiety disorder: analysis of efficacy for different clinical subgroups and symptom dimensions
Dan J Stein, Siegfried Kasper,
Elisabeth Anne Wreford Andersen
, Rico Nil, Malcolm Lader
Section of Biostatistics
34
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Escitalopram in the treatment of social anxiety disorder: analysis of efficacy for different clinical subgroups and symptom dimensions'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Escitalopram
100%
Symptom Dimensions
100%
Clinical Cohort
100%
Social Anxiety Disorder
100%
Clinical Symptoms
100%
Liebowitz Social Anxiety Scale
25%
Disability
25%
Treatment Effect
25%
Factor Analysis
25%
Acute Treatment
12%
Patient Subgroups
12%
Relapse Prevention
12%
Randomized Placebo-controlled Trial
12%
Depressive Symptoms
12%
Symptom Severity
12%
Selective Serotonin Reuptake Inhibitors
12%
Comorbid
12%
Placebo
12%
General Linear Model
12%
Differential Response
12%
Long-term Treatment
12%
Young Patients
12%
Heterogeneous Disorder
12%
Older Patients
12%
Scale Factor
12%
Female Patients
12%
Prevention Studies
12%
Placebo-controlled Trial
12%
Male Patients
12%
Neuroscience
Social Anxiety Disorder
100%
Escitalopram
100%
Placebo
37%
Depressive Disorder
12%
Relapse Prevention
12%
Selective Serotonin Reuptake Inhibitor
12%